Publication:
The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer

dc.contributor.buuauthorGürel, S.
dc.contributor.buuauthorDolar, Mahmut Enver
dc.contributor.buuauthorYerci, Ömer
dc.contributor.buuauthorSamlı, B.
dc.contributor.buuauthorÖztürk, H.
dc.contributor.buuauthorNak, Selim Giray
dc.contributor.buuauthorGülten, Macit
dc.contributor.buuauthorMemik, Faruk
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentGastroenteroloji Ana Bilim Dalı
dc.contributor.departmentPatoloji Ana Bilim Dalı
dc.contributor.researcheridAAG-9177-2021
dc.date.accessioned2021-06-24T07:55:50Z
dc.date.available2021-06-24T07:55:50Z
dc.date.issued1999
dc.description.abstractGastric carcinoma is one of the most common carcinomas and a leading cause of death from cancer in Turkey. The relationship between clinicopathological features of the disease and oncogenes is under investigation. In this retrospective study we investigated the relationships between expression of c-erbB-2 oncoprotein and grade, stage and pathological characteristics of the tumour, and prognosis. Formalin-fixed, paraffin-embedded tissue sections were prepared from gastrectomy specimens from 55 patients with gastric carcinoma. The tissue sections were stained immunohistochemically to reveal c-erbB-2 protein. Six (10%) of the tumours stained positively for c-erbB-2 protein. There was no statistically significant association (P > 0.5) between c-erbB-2 staining and tumour grade, stage or pathological characteristics (necrosis, lymph-node infiltration), or between staining and prognosis. The results suggest that overexpression of c-erb-B-2 protein is not related to the pathological characteristics of the tumour in gastric carcinoma and is not an important prognostic indicator.
dc.identifier.citationGürel, S. vd. (1999). "The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer". Journal of International Medical Research, 72(2), 74-78.
dc.identifier.endpage78
dc.identifier.issn0300-0605
dc.identifier.issue2
dc.identifier.pubmed10446693
dc.identifier.scopus2-s2.0-0344348912
dc.identifier.startpage74
dc.identifier.urihttps://doi.org/10.1177/030006059902700203
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/030006059902700203
dc.identifier.urihttp://hdl.handle.net/11452/20814
dc.identifier.volume27
dc.identifier.wos000081397900003
dc.indexed.scopusScopus
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherCambridge Med Publ
dc.relation.journalJournal of International Medical Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectC-erbB-2 oncoprotein
dc.subjectGastric carcinoma
dc.subjectClinicopathological features
dc.subjectPrognosis
dc.subjectHuman-breast-cancer
dc.subjectLong-term survival
dc.subjectGenetic alterations
dc.subjectOverexpression
dc.subjectAmplification
dc.subjectStomach
dc.subjectAdenocarcinoma
dc.subjectProtein
dc.subject.wosMedicine, research & experimental
dc.subject.wosPharmacology & pharmacy
dc.titleThe relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer
dc.typeArticle
dc.wos.quartileQ3 (Medicine, research & experimental)
dc.wos.quartileQ4 (Pharmacology & pharmacy)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Gastroenteroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Patoloji Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: